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Background
Little is known about the household economic costs associated
with mental, neurological and substance use (MNS) disorders in
low- and middle-income countries.
Aims
To assess the association between MNS disorders and house-
hold education, consumption, production, assets and financial
coping strategies in Ethiopia, India, Nepal, Nigeria, South Africa
and Uganda.
Method
We conducted an exploratory cross-sectional household survey
in one district in each country, comparing the economic cir-
cumstances of households with an MNS disorder (alcohol-use
disorder, depression, epilepsy or psychosis) (n = 2339) and
control households (n = 1982).
Results
Despite some heterogeneity between MNS disorder groups and
countries, households with a member with an MNS disorder had
generally lower levels of adult education; lower housing stan-
dards, total household income, effective income and non-health
consumption; less asset-based wealth; higher healthcare
expenditure; and greater use of deleterious financial coping
strategies.
Conclusions
Households living with a member who has an MNS disorder
constitute an economically vulnerable group who are suscep-
tible to chronic poverty and intergenerational poverty
transmission.
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Background
The economic costs associated with physical illness in households in
low- and middle-income countries (LMICs) have been well docu-
mented.1,2 However, less is known about the household economic
costs associated with mental, neurological and substance use
(MNS) disorders, which have long been neglected in international
health and development policy3,4 but have now been included in
the sustainable development goals.5 Research that examines the
household economic costs associated with MNS disorders in
LMICs can help to reveal how MNS disorders affect household eco-
nomic welfare and identify who should be offered financial risk pro-
tection, with the goal of improving equity. In the case of MNS
disorders, need for care and access to care are often inversely
related: those with the highest need (poor, economically vulnerable,
marginalised populations), tend to have the least access to care.6
MNS disorders and poverty are related in a mutually reinforcing
negative cycle, characterised by social causation and social drift
pathways.7,8
Household-level data are important when examining the
economic impact of MNS disorders in LMICs for a number of
reasons: (a) economic shocks such as catastrophic health
expenditure (defined as out-of-pocket healthcare payments that
exceed a household’s available economic resources) are usually mea-
sured at the household level; (b) opportunity costs (defined as lost
alternative courses of action) associated with MNS disorders such
as additional caregiver burden can be more accurately captured
by examining households; (c) decisions about treatment seeking
and coping with economic consequences of illness are often made
at the household level;1 (d) households often experience interge-
nerational transmission of poverty; and (e) erosion of assets over
time is often felt at the household level. There are several ways in
which MNS disorders may differ from classic descriptions of the
medical poverty trap:9 the household economic impact of MNS dis-
orders is likely to be felt through disability and morbidity rather
than mortality; it is likely to focus on chronic recurrent economic
shocks, rather than single acute shocks, as MNS disorders are
likely to endure and are often episodic; there are likely to be ‘spill-
over’ effects at the household level whereby caring for a person
with an MNS disorder in the household may affect the mental
health of other household members;10 MNS disorders are often dif-
ficult to detect and stigma often prevents help-seeking, further
entrenching the medical poverty trap; and finally, because MNS
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disorders are frequently hidden and highly stigmatised, there are a
range of measurement challenges that exist for the investigator,
such as screening or outcome assessment in diverse cultural
contexts.11,12
Study aims
The aim of this study was to assess the association between MNS
disorders and household education, income, consumption, produc-
tion, assets and financial coping strategies in six LMICs: Ethiopia,
India, Nepal, Nigeria, South Africa and Uganda. We developed a
conceptual framework to guide our exploratory analysis of the
data, using a variety of sources2,8,12,13 (see supplementary Fig. 1;
available at https://doi.org/10.1192/bjo.2019.20). We hypothesised
that, compared with control households, households with a
person who has an MNS disorder would (a) be poorer, with less dis-
posable income and lower levels of consumption; (b) have lower
levels of wealth, including fewer assets; (c) incur greater direct
and indirect healthcare costs; and (d) adopt more regressive
financial coping strategies. This study is part of a broader research
consortium, the European Union-funded Emerald (Emerging
mental health systems in low- and middle-income countries)
project.14
Method
Study design
We conducted an exploratory cross-sectional household survey in
one district, defined as an established health administration catch-
ment area, in each of the six countries. The surveys were conducted
in households with a member who was living with one of the prior-
ity MNS disorders established by the programme (alcohol-use
disorder (AUD), depression, epilepsy or psychosis) or a control
household. The study adheres to the STROBE guidelines for the
reporting of observational cross-sectional epidemiological studies.15
Settings
The sites in each country were the Sodo district, Ethiopia; Sehore
district, Madhya Pradesh state, India; Chitwan district, Nepal;
local government areas in and around the city of Ibadan, Nigeria;
Dr Kenneth Kaunda district, South Africa; and Kamuli district,
Uganda. The rationale for the choice of these districts as well as
the district characteristics have been described in detail else-
where.14,16 In brief, the selection of each district was based on the
priorities identified by the local Ministry of Health and the
partner research institution involved in two prospective interven-
tion studies – the Programme for Improving Mental health carE
(PRIME) and STEPCARE, with which the Emerald household
surveys were linked. These districts were representative of low
resource settings in each country, including a diverse range of
rural, semi-rural and urban settings (to maximise the generalisabil-
ity of our findings), where we were able to establish partnerships for
implementation with local Ministry of Health district health man-
agers or non-governmental organisations.
Participants
From July 2014 to September 2015 we recruited people identified
with AUD, depression, epilepsy or psychosis via individual-level
screening and assessment of primary healthcare clinic attenders in
the district sites by primary healthcare workers using the World
Health Organization (WHO) mhGAP Intervention Guide.17
Exceptions were (a) the psychosis and epilepsy groups in
Ethiopia, which were recruited using community ascertainment
methods because of low facility attendance; and (b) the depression
group in Nigeria, which was recruited through screening and a con-
firmatory diagnosis of major depression using the short form of the
Composite International Diagnostic Interview.18
Participants were recruited through separate, ethically approved
studies: STEPCARE in Nigeria and PRIME in Ethiopia, India,
Nepal, South Africa and Uganda.18,19 The selection of specific dis-
order groups was made by each country team, depending on the
policy and research priorities within each country, and the resulting
focus of the PRIME and STEPCARE studies. After participants
were recruited from clinics in the PRIME and STEPCARE studies,
we then obtained participants’ permission to interview them in
their home for the Emerald study. The Emerald study therefore
involved a separate informed consent and data-collection process,
and addressed a distinct research question to the PRIME and
STEPCARE studies. The inclusion and exclusion criteria and
recruitment processes are summarised in Supplementary Table 1,
and described in detail elsewhere.18,20
For a comparison group, we recruited individuals who were
attending the same primary healthcare clinics for a physical
health complaint, and who screened negative for an MNS disorder.
This group was selected as a comparison in order to identify the net
excess economic burden of MNS disorders on households. Changes
in consumption and production for households affected by a health
condition should be compared with those for households without
the health condition if the intent is to estimate the actual (rather
than imputed) losses in production ascribed to the health condition
itself.12 An exception was the comparison group that was identified
for the Ethiopian psychosis and epilepsy groups, for whommatched
households were identified through the population census. The
rationale for this exception was that these Ethiopian groups were
recruited using community ascertainment methods, rather than
through primary care clinics, and therefore matched households
were a more appropriate comparison.
Individuals who were identified using these methods in the five
groups (AUD, depression, epilepsy, psychosis and controls) were
then asked if they would consent to being visited in their homes
to complete a household questionnaire regarding their social and
economic circumstances. If they consented, participants were
visited in their homes where the head of the household was asked
to provide consent to participate, and if they agreed, completed
the questionnaire. The head of the household was defined as the
person who is most knowledgeable about the household’s health
status, employment, financial condition, expenditures and/or the
main decision-maker in the household. This person was identified
by the household themselves. The questionnaire took approxi-
mately 1 hour to complete.
To calculate the required sample size, the differences in the pro-
portion of households who incur catastrophic healthcare expendi-
tures was used as the primary outcome measure. A study
conducted by Patel et al (2007) to investigate, among others, the
financial burden of depressive disorders in India reported that the
proportions of households with catastrophic healthcare expendi-
tures was 14.6% and 4.9% for households that have members with
depression and those that do not, respectively.21 Based on these
proportions, a power of 80%, and a 95% confidence interval, a
two-sample comparison of proportions was conducted in order to
estimate the minimum sample size required to detect whether
differences exist in rates of catastrophic health expenditure.
According to these calculations, the appropriate sample size for
detecting differences between these proportions was determined
to be 166 for each disorder and control group. Because of concerns
regarding loss to follow-up in our planned longitudinal study, we
recruited additional participants to reduce the impact of loss to
follow-up, where we were able to.
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Measures
Key variables and the instruments used to measure those variables
are set out in supplementary Table 2. Screening for AUD was con-
ducted using the 10-item Alcohol-Use Disorder Identification Test
(AUDIT),22 and screening for depression was conducted using the
9-item Patient’s Health Questionnaire (PHQ-9).23 The household
survey instrument was based on the previously validated WHO
Study on global AGEing and adult health (SAGE) survey in six
LMICs.24 Details of the construction and assumptions used in
each of the economic outcome measures are elaborated in the
notes for Supplementary Table 2.
Analysis
Our analysis was guided by the above conceptual framework, and
hypotheses presented in the Study aims. Given that this study
sought to examine differences between eachMNS group individually,
compared with the control groups for each country, we generated
dichotomous variables for each disorder group prior to conducting
the analyses. We used frequency distributions and univariable
descriptive statistics for preliminary analysis, to describe and
compare: characteristics of the household head, index patient charac-
teristics, household member characteristics as well as housing char-
acteristics. Mean values were reported for all continuous variables as
measures of central tendency and standard deviations. To assess
differences in characteristics between the screen-positive groups,
compared with the control group, P-values were calculated using
independent-sample t-tests to determine significance. For categorical
variables, differences in frequencies were compared using Pearson’s
chi-square tests.
As a result of the uneven distribution of income and consump-
tion data, median values were reported for all economic estimates as
measures of central tendency, and interquartile ranges (IQR) were
reported. To assess differences in income and consumption
between each MNS group and their control group, P-values were
calculated as follows: differences in means were assessed using inde-
pendent-sample t-tests and differences in medians were assessed
using two-sample Wilcoxon rank-sum (Mann–Whitney) tests. To
test whether the presence of a household member with each
disorder significantly predicted changes to income- and expend-
iture-related outcomes, quantile regression tests were conducted
and predicted median differences and confidence intervals were
reported. Quantile regression was chosen (as opposed to ordinary
least squares (OLS) regression) to estimate the median of the
dependent variable (income, consumption) conditional on
whether or not the household includes a member living with an
MNS disorder (i.e. the independent variable). Both OLS and
quantile regression describe central tendency of data – of which
the former uses the mean, and the latter uses the median.
Consequently, OLS is much more sensitive to outliers and skewed
distributions. Given that the outcomes of interest were non-para-
metric, Stata’s quantile regression function was used to predict the
median which by default, conducts median regression estimation.
Quantile regression is more robust to outliers and non-normal
errors and allows the analyst to explore the impact of the variable
of interest on the entire distribution of the outcome, not simply
its mean.
Kernel density estimates were used to examine the asset scores
derived through multiple correspondence analysis for the control
households and for each MNS disorder group. Differences in the
overall trends of asset-based wealth scores were assessed using
two-sample Wilcoxon rank-sum (Mann–Whitney) tests given that
the distributions were not normally distributed. Differences in the
overall trends of log consumption were assessed using independ-
ent-sample t-tests.
For handling missing data, if households did not provide data
on the key economic outcomes (income, assets, consumption and
health expenditure), they were not included in the analyses. If the
household respondent did not provide itemised income, consump-
tion or health expenditure data, but was able to estimate the total for
each category, these estimates were used. Participants who were
excluded did not have any significant differences with respect to
their sociodemographic characteristics when compared with those
participants who were included in the final analyses. No imputation
methods were used in the analysis.
Ethical considerations
The consenting process for the study involved two stages. First, par-
ticipants with one of the MNS disorders or controls were invited to
participate and asked to provide informed consent to participate
and be visited in their homes. Capacity to consent was assessed in
all sites. If consent was given, households were subsequently
visited, where the head of the household was asked to provide
written informed consent. All participants provided voluntary
informed consent to participate in the study, except in the case of
some members of the psychosis group in Ethiopia who lacked cap-
acity to consent. For these participants, guardian permission was
given instead, as long as the person with psychosis did not refuse.
None of the household heads lacked capacity to consent.
India, Nepal, South Africa and Uganda used hand-held elec-
tronic data-collection devices such as smart phones or tablets, and
ensured that data remain secure by (a) password-protecting access
to the hand-held devices, (b) transmitting data to the server regu-
larly, (c) password-protecting the computers that accessed the
server, and (d) accessing raw data on the server via a password-pro-
tected website. Data were collected in Nigeria and Ethiopia using
pen and paper questionnaires, which were kept in locked filing cabi-
nets, and subsequently data were captured on password-protected
computers. The study received ethical approval from the ethics
review committees of the partner institutions in each country, as
well as that of the project coordinating centre (King’s College
London) and WHO (RPC619).
Results
Participant characteristics
The size and characteristics of the MNS disorder and control (non-
mental health) groups varied substantially across Ethiopia (n = 936),
India (n = 1104), Nepal (n = 910), Nigeria (n = 316), South Africa
(n = 617) and Uganda (n = 438) (supplementary Table 3). There
were 16 MNS disorder groups across the six countries, which
varied substantially in size from the psychosis group in South
Africa (n = 21) to the depression group in South Africa (n = 300).
The final sample size was derived after removal of respondents
who had participated in the survey but had >80% incomplete data
(i.e. only household roster was completed) (Fig. 1). Index partici-
pants with MNS disorders presented with a variety of clinical and
functioning profiles. The majority of countries had a higher propor-
tion of male than female household heads, except South Africa.
There were clear differences between households with and those
without an MNS disorder in several respects (supplementary
Table 4). The majority of heads of households with an MNS dis-
order had lower levels of education than heads of households
without a member with an MNS disorder, with the exception of
the AUD group in India, the depression groups in Nigeria
and South Africa, and the psychosis groups in Nepal and Uganda.
A greater proportion of households with an MNS disorder reported
having a member with long-term care needs than households
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without MNS disorders, with the exception of Uganda, which
reported significantly higher proportions of households with long-
term care needs in the non-MNS household group (30.9%). In the
pooled data (combined across countries) (Table 1), there was
some heterogeneity in household sociodemographic data between
disorders. For example, 48.0% of household heads with a member
with psychosis and 39.1% of household heads with a member
with epilepsy had no formal education, compared with 29.6% of
heads of non-MNS households (P < 0.01 and P < 0.05 for psychosis
and epilepsy, respectively), 31.9% of AUD household heads and
25.8% of depression household heads had no formal education.
There was a consistently low level of financial protection
(health insurance cover) in both MNS disorder and the non-
MNS disorder households, across all countries, including volun-
tary or mandatory, and private or social insurance: between 0%
of households in Uganda and 13% of households in India had
health insurance. Housing standards (indicated by access to
improved sanitation facilities) were higher among non-MNS dis-
order households, with the exception of South Africa and small
samples for specific disorders. However, in pooled data, there
was again heterogeneity between disorder groups; whereas psych-
osis and epilepsy groups had significantly less health insurance
Excluded
• Ethiopia (n = 12)
• Household could not be located (n = 7)
• Declined to participate (n = 0)
• Did not meet inclusion criteria: (n = 5)
• India (n = 12)
• Household could not be located (n = 6)
• Declined to participate (n = 6)
• Did not meet inclusion criteria: (n = 0)
• Nepal (n = 139)
• Household could not be located (n = 98)
• Declined to participate (n = 35)
• Did not meet inclusion criteria: (n = 6)
• Nigeria (n = 32)
• Household could not be located (n = 13)
• Declined to participate (n = 19)
• Did not meet inclusion criteria: (n = 0)
• South Africa (n = 20)
• Household could not be located (n = 16)
• Declined to participate (n = 2)
• Did not meet inclusion criteria: (n = 2)
• Uganda (n = 2)
• Household could not be located (n = 2)
• Declined to participate (n = 0)
• Did not meet inclusion criteria: (n = 0)
Participants recruited and initially consented
• Ethiopia (n = 937)
• India (n = 1114)
• Nepal (n = 924)
• Nigeria (n = 325)
• South Africa (n = 643)
• Uganda (n = 447)
Participants excluded for incomplete or
inconsistent data
• Ethiopia (n = 1)
• India (n  = 10)
• Nepal (n = 7)
• Nigeria (n = 3)
• South Africa (n = 5)
• Uganda (n = 9)
Participants included in analyses
• Ethiopia (n = 936)
• India (n = 1104)
• Nepal (n = 910)
• Nigeria (n = 316)
• South Africa (n = 617)
• Uganda (n = 438)
Later refusals
• Ethiopia (n = 0)
• India (n = 43)
• Nepal (n = 7)
• Nigeria (n = 6)
• South Africa (n = 21)
• Uganda (n = 0)
Completed survey
• Ethiopia (n = 937)
• India (n = 1114)
• Nepal (n = 917)
• Nigeria (n = 319)
• South Africa (n = 622)
• Uganda (n = 447)
Eligible households referred by PRIME/SteppedCare
• Ethiopia (n = 949)
• India (n = 1126)
• Nepal (n = 1063)
• Nigeria (n = 357)
• South Africa (n = 663)
• Uganda (n =  449)
Fig. 1 Flow chart of participants in each country.
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coverage (P < 0.01), worse housing floor materials (P < 0.01) and
less improved water (P < 0.01) and sanitation (P < 0.01) than non-
MNS households, this was not the case for depression and AUD
households (Table 1).
The findings of the economic outcomes for all MNS disorder
groups combined across countries (pooled) are summarised in
Table 2.
Income and consumption
In absolute terms, household income per adult equivalent house-
hold member across all sites was extremely low, ranging from US
$4.90 per adult equivalent per month in the epilepsy group in
Uganda to US$72.07 in the control group in Nigeria (supplementary
Table 5). Total household income was consistently lower among
households affected by an MNS disorder, with the exception of
the small epilepsy group in Ethiopia, the depression group in
India and all MNS groups in Uganda.
In terms of effective income, measured here by the level of con-
sumption per adult equivalent household member, households
affected by MNS disorders were consistently found to have lower
monthly household consumption when compared with non-MNS
households with the exception of the AUD and depression groups
in India, the AUD and small psychosis group in Nepal, the depres-
sion group in South Africa, and the depression and small psychosis
groups in Uganda.
In pooled data across countries, there was again heterogeneity
between disorder groups, with epilepsy and psychosis households
showing significantly lower levels of income and consumption, com-
pared with non-MNS households (median monthly income differ-
ence: −US$18.34 (95% CI −23.44 to −13.24), −US$13.42 (95%
CI −17.52 to −9.32) for epilepsy and psychosis, respectively,
P < 0.01; median monthly consumption difference: −US$25.85
(95% CI −30.76 to −20.94), −US$14.46 (95% CI −18.55 to −10.37)
for epilepsy and psychosis respectively, P < 0.01), a trend not
evident in AUD and depression households (Table 2). Nevertheless,
all MNS household groups combined showed significantly lower
total income and consumption than non-MNS households (median
difference: –US$3.55 (95% CI −6.22 to −0.89) and −US$3.41 (95%
CI −6.02 to −0.80), respectively, P < 0.05).
Regarding household capacity to pay (effective income
minus total food consumption), this was consistently lower in
households with an MNS disorder compared with households
without an MNS disorder, with the exception of the depression
group in India, the small psychosis group in Nepal and all
MNS groups in Uganda. Once subsistence needs had been met,
effective income remaining to meet all other needs among
households with an MNS disorder ranged from US$5.26 per
adult equivalent per month in the epilepsy group in Ethiopia
to US$34.77 per adult equivalent per month in the AUD group
in India. In pooled data, households with a member with psych-
osis or epilepsy once again had less effective monthly income
(median difference: −US$14.8 (95% CI −18.68 to −10.91) and
−US$12.01 (95% CI −15.10 to −8.92), respectively, P < 0.01),
than households with depression or AUD, when compared with
non-MNS households (Table 2)
Regarding non-health consumption, there was a similar trend
with most MNS disorder household groups reporting lower levels
of consumption than households without an MNS disorder,
although there was some heterogeneity across the countries. In
Ethiopia, all MNS households had lower non-health consumption
than control households; in India all MNS households had higher
non-health consumption than control households with the excep-
tion of the small psychosis group; in Nepal all MNS households
had lower non-health consumption than control households,
with the exception of the AUD group; in Nigeria depression
group households had lower non-health consumption than
control households; in South Africa, depression group households
had higher non-health consumption than control households
whereas the small psychosis group had lower non-health con-
sumption; in Uganda, all MNS groups had higher non-health con-
sumption than non-MNS households, with the exception of the
epilepsy group.
Asset-based wealth
We found a greater density of non-MNS households in the highest
95th wealth percentile in all countries (Fig. 2). Conversely, there was
a greater density of MNS households in the poorest 50th percentile
in Ethiopia, India, Nepal and Nigeria but this was less evident in
Table 1 Sociodemographic and clinical characteristics of the households across the mental, neurological and substance use (MNS) disorder and non-
MNS (control) household groups, pooled from all countries
Household groups
AUD
(n = 439)
Depression
(n = 1144)
Epilepsy
(n = 286)
Psychosis
(n = 470)
All MNS groups
(n = 2339)
Control group
(n = 1982)
Household head characteristics
Gender, female: % 15.72** 35.38** 33.45* 28.14 29.98* 26.44
Education, no formal education: % 31.89 25.81* 39.08* 47.97** 33.19* 29.55
Indexed patient characteristics
Gender, female: % 6.64** 71.93 47.54** 44.44** 48.57** 76.05
AUDIT score, mean (s.d.) 19.60 (8.13)** 2.12 (5.42)** 2.10 (5.29)** 4.15 (7.89)** 6.29 (9.64)** 0.62 (2.41)
PHQ-9 score, mean (s.d.) 8.56 (4.99)** 12.71 (4.18)** 7.52 (5.59)** 9.72 (7.09)** 10.70 (5.58)** 4.06 (2.93)
WHODAS Simple Score, mean (s.d.) 8.52 (6.49)** 14.58 (8.34)** 13.22 (10.60)* 20.01 (12.05)** 14.28 (10.06)** 10.78 (10.10)
WHODAS Complex Score, mean (s.d.) 20.68 (14.65)** 34.51 (18.35)** 30.36 (23.29) 44.19 (24.99)** 33.06 (21.58)** 25.81 (23.04)
Household characteristics
Household size, mean (s.d.) 5.45 (2.33) 4.90 (2.41)** 6.00 (2.77)** 5.41 (2.56) 5.24 (2.50) 5.38 (2.61)
Health insurance coverage, insured households: % 9.11* 3.50* 1.05** 1.70** 3.93* 5.30
Housing characteristics
Floor material, hard floors: % 38.95** 62.15** 27.62** 25.85** 46.32 46.99
Sanitation source, improved sanitation: % 46.01 59.27** 30.07** 27.08** 46.77* 49.87
Water source, improved water source: % 83.37 86.36** 79.72 67.45** 81.20 83.25
AUD, alcohol-use disorder; AUDIT, Alcohol-Use Disorder Identification Test; PHQ-9, 9-item Patient’s Health Questionnaire; WHODAS, World Health Organization Disability
Assessment Schedule.
* P < 0.05 and **P < 0.01.
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Table 2 Pooled economic outcomes, comparing mental, neurological and substance use (MNS) households with non-MNS (control) households across all country sitesa
Household groups
Alcohol-use disorder
(n = 439)
Depression
(n = 1144)
Epilepsy
(n = 286)
Psychosis
(n = 470)
All MNS groups
(n = 2339)
Control group
(n = 1982)
Household income per adult equivalent (monthly, USD$)
Median (IQR) 40.95 (47.15)** 33.09 (56.36)** 11.13 (20.88)** 16.11 (26.23)** 25.95 (48.70)* 29.53 (50.71)
Median difference (95% CI) 11.43 (6.75 to 16.10) 3.63 (0.18 to 7.09) −18.34 (−23.44 to −13.24) −13.42 (−17.52 to −9.32) −3.55 (−6.22 to −0.89) Reference
Household consumption (effective income) per adult equivalent (monthly, USD$)
Median (IQR) 63.2 (39.52)** 53.33 (52.97) 26.37 (27.61)** 37.86 (40.67)** 49.00 (48.75)* 52.41 (49.35)
Median difference (95% CI) 10.78 (6.45 to 15.11) 1.06 (−2.11 to 4.23) −25.85 (−30.76 to −20.94) −14.46 (−18.55 to −10.37) −3.41 (−6.02 to −0.80) Reference
Household capacity to pay per adult equivalent (monthly, USD$)
Median (IQR) 31.41 (30.90)** 24.81 (34.08)** 8.25 (12.85)** 11.06 (18.13)** 20.37 (31.28)* 23.08 (33.16)
Median difference (95% CI) 8.3 (4.87 to 11.73) 1.78 (−0.64 to 4.20) −14.8 (−18.68 to −10.91) −12.01 (−15.10 to −8.92) −2.7 (−4.64 to −0.76) Reference
Household non-health consumption per adult equivalent (monthly, USD$)
Median (IQR) 57.05 (36.14)** 49.30 (47.84) 25.01 (24.8)** 35.7 (39.74)** 44.56 (42.78)* 47.73 (42.86)
Median difference (95% CI) 9.24 (5.43 to 13.05) 1.51 (−1.40 to 4.42) −22.76 (−27.28 to −18.25) −12.05 (−15.82 to −8.28) −3.24 (−5.49 to −0.99) Reference
Out-of-pocket (OOP) health expenditure per adult equivalent (monthly, USD$)
Median (IQR) 2.85 (7.96)** 2.08 (6.16)** 0.82 (2.32)** 1.38 (3.36) 1.80 (5.25)** 1.59 (5.56)
Median difference (95% CI) 1.25 (0.77 to 1.74) 0.50 (0.14 to 0.86) −0.78 (−1.29 to −0.27) −0.21 (−0.63 to 0.21) 0.20 (−0.07 to 0.46) Reference
Catastrophic OOP health expenditure, %
Households where OOP health expenditure >10% effective Income 31.66** 25.96 22.38 22.77 25.94 23.97
Households where OOP health expenditure >40% capacity to pay 12.98 12.59 15.03 23.19** 15.09* 12.92
Household use of coping strategies in response to financial distress
Households using cost-minimisation strategies, % 35.99 37.85** 66.78** 51.60** 43.78** 32.04
Households using cost-minimisation strategies, OR (95% CI) 1.19 (0.96 to 1.48) 1.29 (1.11 to 1.50) 4.27 (3.28 to 5.55) 2.26 (1.84 to 2.77) 1.65 (1.46 to 1.87) Reference
Households using cost-management strategies, % 89.29** 76.92 86.01** 74.89 79.96** 75.73
Households using cost-management strategies, OR (95% CI) 2.67 (1.94 to 3.68) 1.07 (0.90 to 1.27) 1.97 (1.39 to 2.80) 0.96 (0.76 to 1.21) 1.28 (1.11 to 1.48) Reference
Number of concurrent strategies used, mean (s.d.) 3.34 (2.19)** 2.53 (2.11) 3.78 (2.35)** 2.78 (2.25)** 2.88 (2.23)** 2.44 (2.06)
Number of concurrent strategies used, β (95% CI) 0.90 (0.68 to 1.11) 0.09 (−0.06 to 0.24) 1.34 (1.08 to 1.60) 0.34 (0.13 to 0.55) 0.44 (0.31 to 0.57) Reference
a. Analyses overview: for all financial estimates median values and interquartile ranges (IQR) are reported as measures of central tendency and overall differences in their distributions were assessed using two-sample Wilcoxon rank-sum (Mann–Whitney) tests with
dichotomous disorder group variables. In some instances, crude median differences were not precisely equivalent to median differences assessed through quantile regression estimation because of rounding. Differences between each disorder group and the non-MNS
(control) group were assessed using Pearson’s chi-square tests. Logistic regression was used to determine the impact of having a household member with each disorder on use of coping strategies, compared with the non-MNS (control) group using dichotomous disorder
variables; ORs are reported. To test whether the presence of a household member with each disorder significantly predicts changes to the number of coping strategies being employed in response to financial distress, regression tests were conducted and beta (β) coefficients
are reported. The non-MNS (control) group was used as the referent group for all comparisons and tests of associations.
* P < 0.05 and **P < 0.01.
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South Africa and Uganda. The greater density was more pro-
nounced in households with psychosis and epilepsy, in keeping
with the pooled analysis of income and consumption across coun-
tries (Table 2). The difference in the distribution of asset scores
was significant for Ethiopia, India, Nepal and Nigeria, with the
exception of the depression groups in Ethiopia and India and
the small psychosis group in Nepal. The trend was most pro-
nounced in Nigeria where 18.8% of the non-MNS households
were in the highest quintile compared with 7.2% of the depression
group households, and 20.3% of the control households were in
the lowest quintile compared with 49.4% of the depression group
households.
Healthcare expenditure
Across most settings, households with an MNS disorder reported
higher rates of any healthcare expenditure when compared with
non-MNS households, with the exception of the depression group
households in India, the AUD and small sample of epilepsy group
households in Nepal and the depression group households in
Nigeria and South Africa. In absolute terms, households with an
MNS disorder reported higher healthcare expenditure than house-
holds without an MNS disorder, with the exception of the AUD and
psychosis groups in India, the AUD group in Nepal and the depres-
sion group in Nigeria (Supplementary Table 6). Out-of-pocket
healthcare expenditure ranged from US$0.30 per adult equivalent
per month in the epilepsy group in Ethiopia, to US$5.54 in the
psychosis group in Nepal. In the pooled analysis (Table 2), out-
of-pocket healthcare expenditure was significantly higher in AUD
and depression groups (median monthly difference: US$1.25
(95% CI 0.77 to 1.74) and US$0.50 (95% CI 0.14 to 0.86), P < 0.01)
compared with non-MNS households, and significantly lower in
the epilepsy group (median monthly difference: −US$0.78 (−1.29
to −0.27), P < 0.01).
There were high proportions of all households reporting cata-
strophic health expenditure, whether it was defined as 10% or
more of effective income or as 40% of capacity to pay. Compared
with control households, higher proportions of catastrophic
health expenditure were reported in all MNS households in
Ethiopia, depression group households in India, psychosis group
households in Nepal and depression group households in Nigeria.
There was lower catastrophic health expenditure for the MNS
households in South Africa and inconsistent findings in Uganda.
In the pooled data, there were similarly heterogeneous findings
across disorder groups in relation to catastrophic health expenditure
(Table 2).
Financial coping strategies
In relation to financial coping strategies, a higher proportion of
households with an MNS disorder reported using current cost-
minimisation strategies (for example restricting food, use of health-
care or withdrawing children from school to minimise household
consumption) than households without an MNS disorder (odds
ratio (OR) = 1.65, 95% CI 1.46–1.87, P < 0.01) for all MNS disorders
combined (Table 2). The only exception was the small psychosis
group in South Africa. These trends were significantly higher in
Ethiopia (all groups), Nepal (all groups), Nigeria (depression
group) and South Africa (depression group). Cost-minimisation
strategies were widely used by households with an MNS disorder
across all countries, including 54.8% in Ethiopia, 36.1% in India,
32.5% in Nepal, 43.2% in Nigeria, 22.7% in South Africa and
86.2% in Uganda.
Cost-management strategies (including borrowing from social
networks, finding extra work, exhausting savings and taking out
loans from money lenders in response to financial difficulty) were
more prevalent among households with an MNS disorder than
households without an MNS disorder in all countries (OR = 1.28,
95% CI 1.11–1.48, P < 0.01) for all MNS disorders combined
(Table 2). Some exceptions were found in the epilepsy group in
Ethiopia, the small psychosis groups in India and Nepal and the
depression and small psychosis groups in South Africa. Cost-man-
agement strategies were widely used by MNS disorder households
across all countries, including 69.5% in Ethiopia, 93.1% in India,
78.7% in Nepal, 84.1% in Nigeria, 61.7% in South Africa and
95.1% in Uganda.
Additionally, households with MNS disorders were consistently
making use of a greater number of concurrent distress financing
strategies in response to financial difficulty than households
without MNS disorders (OR = 0.44, 95% CI 0.31–0.57, P < 0.01)
for all MNS disorders combined (Table 2). These were significantly
higher for all disorder groups in Ethiopia, AUD in India, all disorder
groups in Nepal, depression in Nigeria and all disorder groups in
Uganda. This trend was more pronounced for households with
psychosis. The mean number of concurrent strategies being used
by MNS households was 2.4 in Ethiopia, 3.4 in India, 3.0 in
Nepal, 2.8 in Nigeria, 1.2 in South Africa and 4.8 in Uganda.
Discussion
Main findings
This study provides new evidence on the household economic costs
associated with MNS disorders in LMICs. Despite diverse social,
economic and cultural contexts in Ethiopia, India, Nepal, Nigeria,
South Africa and Uganda, we found a relatively consistent
pattern, namely that households living with someone with an
MNS disorder are economically worse off than control households,
using a variety of assessment measures. With some notable excep-
tions, households with an MNS disorder had lower levels of adult
education (in 11 of 16 MNS disorder groups), lower housing stan-
dards indicated by access to improved sanitation facilities (10/16),
lower total household income (11/16), lower effective income
(9/16), lower non-health consumption (10/16), less asset-based
wealth (10/16), higher healthcare expenditure (12/16) and greater
use of deleterious financial coping strategies, including cost man-
agement (11/16), cost minimisation (15/16) and higher numbers
of concurrent distress financing strategies (13/16).
Income, consumption and wealth differences and financial
coping strategy differences between MNS and control households
were more extreme for psychosis and epilepsy than for depression
and AUD. This may be indicative of more pronounced lost produc-
tion opportunities or more constant healthcare spending as a result
of the chronic and more disabling nature of psychosis and epilepsy,
but further research is required to test these hypotheses.
Our findings showed that households affected by MNS disor-
ders have lower effective incomes available to them once their
basic subsistence needs have been met, when compared with house-
holds without a person with an MNS disorder. In absolute terms
these households have extremely limited resource availability to
meet the (non-food) needs of their households. In contexts such
as these, households are likely forced to make difficult decisions
around whether to use these resources for education, housing or
healthcare with substantial opportunity costs for all household
members.
Interpretation of our findings
Similar to findings from a previous systematic review,11 there was
some heterogeneity with respect to non-health consumption com-
paring households with a member with an MNS disorder to those
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without, and this may be explained by two possible considerations.
First, in settings where there were no differences between these
groups, households may be mitigating risks to their non-health con-
sumption against the impact of the MNS disorder through cost-
minimisation strategies, cost-management strategies and increased
access to transfers from family members, community groups and
government grants. The increased use of deleterious coping strat-
egies evident in MNS households are likely to allow those house-
holds to maintain levels of consumption, despite the resulting
long-term negative consequences for the assets and livelihood of
these households.
Second, where households with a member with an MNS dis-
order were found to have higher non-health consumption com-
pared with the control households, this may suggest these
households are making less use of healthcare (and therefore incur-
ring a lesser amount of health consumption) when compared with
the control households affected by physical health concerns.
With respect to out-of-pocket health expenditure, households
that are not affected by an MNS disorder more often report no
health expenditure, and in absolute terms, of those that did incur
health expenditure, households affected by MNS disorder are
spending a higher amount on healthcare compared with households
that are not affected by MNS disorder. The households living with a
person with anMNS disorder are also on average spending a greater
share of their capacity to pay on healthcare, when compared with
the control households. However, households that are unaffected
by MNS disorders that did incur health expenditure more often
met the threshold for catastrophic health spending when compared
with the MNS households. This could suggest that although house-
holds that are not affected by MNS disorder make use of healthcare
more infrequently, among those that do, their healthcare needs may
be more acute and severe with higher costs (such as admissions to
hospital) compared with households with a member with an MNS
disorder who use healthcare more frequently to support longer-
term, chronic care needs.
Differences between disorder groups in the pooled analysis are
also worth noting: out-of-pocket payments are higher in depression
and AUD groups than the psychosis and epilepsy groups. This may
be because the psychosis/epilepsy group are already substantially
poorer and have shifted themselves to a level of poverty that
means that they no longer can spend money on healthcare. This
is supported by their lower income and consumption and higher
use of regressive financial coping strategies – including reducing
food intake that affects the denominator for catastrophic costs.
This finding may also indicate that the measurement of catastrophic
healthcare costs in isolation can be misleading in situations of
extreme poverty.
Implications
Perhaps one of the more striking findings was that households with
a person with an MNS disorder are adopting a range of deleterious
coping strategies in response to financial hardship that are
significantly more regressive than households without an MNS
disorder – a finding that was perhaps most consistent across dis-
order groups and across countries, of all the economic outcome
measures we included. These coping strategies include withdrawing
children from school, restricting food intake, restricting healthcare,
using savings, taking out loans and accounts at shops, and asking
employers and other social networks for help. Use of these strategies
provides the evidence that current and future non-health consump-
tion choices are being compromised, including savings and assets
and human capital formation of children. The consequences are
lifelong and can contribute to intergenerational transmission of
poverty.25
Exceptions
Despite the overall trend that households with an MNS disorder are
financially worse off, there are important exceptions (noted above).
One reason for the exceptions may be the small sample sizes for
some groups, for example the psychosis group in South Africa
(n = 21), the epilepsy group in Nepal (n = 36), the psychosis group
in India (n = 31), and the depression (n = 53) and psychosis (n =
46) groups in Uganda. Second, South Africa was an exception in
several instances, possibly as a result of its extensive social welfare
system, which acts as a buffer for households, reducing the eco-
nomic impact of disabilities such as those associated with MNS
disorders. South Africa also has a free healthcare system, despite
ongoing challenges of access and quality, which may explain the
lack of difference between groups in healthcare expenditure. In add-
ition, participants from control households in South Africa were
recruited from chronic disease clinics, which provide treatment
for HIV, tuberculosis and chronic non-communicable diseases,
and these chronic disabling conditions are also likely to have a sub-
stantial independent negative impact on household economic status
in the control households. Third, Uganda was an exception in
several instances, and this may be explained by both small sample
sizes for two groups and the presence of a high proportion of indi-
viduals with long-term care needs in the control households.
In addition, it is important to note that each comparison is
between a disorder group and its relevant comparison group, and
that the comparisons were not undertaken between disorder
groups. We believe this is important as the household-level eco-
nomic dynamics of different disorders are likely to be very different.
For example, the economic impact of AUDs include both the direct
costs of consumption of alcohol as well as the disabling effects of the
disorder; whereas the economic impact of depression does not carry
the same direct costs, but is nevertheless disabling, reducing prod-
uctivity and consuming carer time. The details of the findings
per disorder and per country are presented in supplementary
Tables 4, 5 and 6, and the data will be subject to further analysis
through country-specific papers.
Limitations
This study has a number of limitations, which need to be noted.
First, the cross-sectional survey design makes it difficult to draw
conclusions regarding causality or the direction of the relationship
between household economic adversity and MNS disorders.7
Second, large-scale quantitative studies may overlook the dynamics
of specific household financial strategies and attempts to cope with
adversity. Third, this study did not quantify the indirect healthcare
costs associated with accessing health services, potentially under-
estimating the rates of catastrophic health spending across the
study sites. Evidence from several studies conducted in LMICs
has suggested that indirect costs associated with healthcare
seeking often exceed the direct costs, with some estimates indicating
indirect cost burdens to be 2 to 3.6 times greater than direct cost
burdens.2,26–30 In addition, given the levels of deprivation that
exist in our study sites, lower thresholds of catastrophic health
consumption should be examined.
Fourth, although our household sample(s) were recruited based
on the presence of onemember with anMNS disorder, identified via
separate studies, we were not able to screen all household members
for MNS disorder or other chronic diseases and were therefore
unable to examine and control for the impact of having multiple
household members with an MNS disorder or other disabling
health conditions. Households within our control group could
have therefore also included members affected by an MNS disorder.
Fifth, by pooling data across diverse country settings (shown in
Table 2), we run the risk of glossing over considerable heterogeneity
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in sample sizes, case detection methods and other variables. The
pooled findings should therefore be interpreted with caution, and
read alongside the country-specific data presented in supplemen-
tary Tables 5 and 6. Sixth, our selection of MNS disorders in this
study was limited by the priorities of the Ministries of Health and
the PRIME and STEPCARE studies, with which the Emerald house-
hold surveys were linked. Finally, apart from the quantile regres-
sions, we did not conduct in-depth regression analyses in this
paper, to determine which factors were associated with worse eco-
nomic circumstances in households living with MNS disorders.
These further analyses will be explored in more detail in country-
specific publications from this data-set.
Further longitudinal research is required to examine possible
causal mechanisms in the relationship between MNS disorders
and household economic status in LMICs. Qualitative research in
specific local settings will also be required to understand the house-
hold economic dynamics involved in living with a family member
with an MNS disorder, for example the complex relationships
between income, consumption, assets and financial coping
strategies.
Our study includes people who were generally attending
primary care facilities for a physical health complaint and were
also screened positive for an MNS disorder. Although we did not
conduct an assessment of physical health needs, it is likely that
there were therefore high levels of comorbidity betweenMNS disor-
ders and physical health problems in these participants. This has
two important policy implications: first, the high comorbidity
between physical health and MNS disorders in primary care popu-
lations has been frequently documented, and primary care
programmes need to adopt an integrated approach that addresses
both the physical and mental health needs of people who use
these services. Second, our estimates of the economic burden of
MNS disorders is likely to underestimate this burden in relation
to the general (healthy) population, as our comparison group
included people who had other physical health complaints and
therefore were likely to have incurred other economic costs
associated with their physical health condition.
Recommendations
There are several recommendations for policymakers. This study
presents striking findings regarding the adverse household eco-
nomic circumstances associated with having a family member
with an MNS disorder. Protection of households from economic
vulnerability, including shocks are given specific attention in the
sustainable development goals, particularly goal 1.5. Our findings
indicate that households living with a person with an MNS disorder
constitute an economically vulnerable population, who are highly
susceptible to chronic poverty and intergenerational poverty trans-
mission and who merit development assistance. In broad terms this
should come in two forms. First, improved access to evidence-based
care and rehabilitation is essential, delivered using primary care and
community-based platforms, as currently being developed and
scaled up through PRIME,19 and other global mental health innova-
tions.31 The strikingly low levels of health insurance cover across all
countries, and the lack of access to mental health services point
clearly to the need for the treatment of MNS disorders to be
included in universal health coverage packages of care, as set out
in the sustainable development goals.3,32
Second, it is essential to improve financial assistance to house-
holds living with MNS disorders in the form of disability grants
or cash transfers. There is robust emerging evidence for the benefits
of cash transfers for economic welfare, mental health, well-being,
reductions in stress (measured using salivary cortisol) and domestic
violence.33,34
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